Hypertension:降低尿酸水平可以改善肥胖青少年血压升高

2012-10-03 高晓方译 医学论坛网

  美国学者的一项研究表明,在高血压前期青少年中,尿酸所致的血压升高可通过降低尿酸加以缓解。论文于2012年9月24日在线发表于《高血压》(Hypertension)杂志。   此项随机、双盲、安慰剂对照试验以高血压前期肥胖青少年为受试者。受试者被随机分配接受黄嘌呤氧化酶抑制剂、别嘌呤醇、排尿酸药、丙磺舒或安慰剂治疗,并就尿酸是否为血压升高的归因介质以及是否损害血管顺应性加以评估。   结果显

  美国学者的一项研究表明,在高血压前期青少年中,尿酸所致的血压升高可通过降低尿酸加以缓解。论文于2012年9月24日在线发表于《高血压》(Hypertension)杂志。

  此项随机、双盲、安慰剂对照试验以高血压前期肥胖青少年为受试者。受试者被随机分配接受黄嘌呤氧化酶抑制剂、别嘌呤醇、排尿酸药、丙磺舒或安慰剂治疗,并就尿酸是否为血压升高的归因介质以及是否损害血管顺应性加以评估。

  结果显示,接受降尿酸治疗的受试者血压显著降低,收缩压和舒张压分别降低10.2 mmHg和9.0 mmHg;对照者的收缩压和舒张压则分别升高1.7 mmHg和1.6 mmHg。降低尿酸同时使全身血管阻力显著降低。

拓展阅读:

ARD:血尿酸盐正常高限也增高血压风险(CARDIA研究)

WCN 2011:血尿酸与高血压患者终末器官损伤相关 (热

原始文献: 

Soletsky B, Feig DI. Uric Acid Reduction Rectifies Prehypertension in Obese Adolescents. Hypertension. 2012 Sep 24.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1725455, encodeId=cbf51e25455d9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 22 15:04:00 CST 2013, time=2013-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718927, encodeId=1b0e1e189278f, content=<a href='/topic/show?id=32b888935ca' target=_blank style='color:#2F92EE;'>#血压升高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88935, encryptionId=32b888935ca, topicName=血压升高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c86e32676392, createdName=zhang92571, createdTime=Fri Dec 28 04:04:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038445, encodeId=d14320384451c, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Fri May 24 17:04:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501002, encodeId=f4b61501002f2, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Oct 05 01:04:00 CST 2012, time=2012-10-05, status=1, ipAttribution=)]
    2013-04-22 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1725455, encodeId=cbf51e25455d9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 22 15:04:00 CST 2013, time=2013-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718927, encodeId=1b0e1e189278f, content=<a href='/topic/show?id=32b888935ca' target=_blank style='color:#2F92EE;'>#血压升高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88935, encryptionId=32b888935ca, topicName=血压升高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c86e32676392, createdName=zhang92571, createdTime=Fri Dec 28 04:04:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038445, encodeId=d14320384451c, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Fri May 24 17:04:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501002, encodeId=f4b61501002f2, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Oct 05 01:04:00 CST 2012, time=2012-10-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1725455, encodeId=cbf51e25455d9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 22 15:04:00 CST 2013, time=2013-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718927, encodeId=1b0e1e189278f, content=<a href='/topic/show?id=32b888935ca' target=_blank style='color:#2F92EE;'>#血压升高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88935, encryptionId=32b888935ca, topicName=血压升高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c86e32676392, createdName=zhang92571, createdTime=Fri Dec 28 04:04:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038445, encodeId=d14320384451c, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Fri May 24 17:04:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501002, encodeId=f4b61501002f2, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Oct 05 01:04:00 CST 2012, time=2012-10-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1725455, encodeId=cbf51e25455d9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 22 15:04:00 CST 2013, time=2013-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718927, encodeId=1b0e1e189278f, content=<a href='/topic/show?id=32b888935ca' target=_blank style='color:#2F92EE;'>#血压升高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88935, encryptionId=32b888935ca, topicName=血压升高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c86e32676392, createdName=zhang92571, createdTime=Fri Dec 28 04:04:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038445, encodeId=d14320384451c, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Fri May 24 17:04:00 CST 2013, time=2013-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501002, encodeId=f4b61501002f2, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11ff9497046, createdName=jambiya, createdTime=Fri Oct 05 01:04:00 CST 2012, time=2012-10-05, status=1, ipAttribution=)]